ASX:BIT Biotron (BIT) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Biotron Stock (ASX:BIT) 30 days 90 days 365 days Advanced Chart Get Biotron alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1.03 million shsAverage VolumeN/AMarket CapitalizationA$9.93 millionP/E RatioN/ADividend Yield5.08%Price TargetN/AConsensus RatingN/A Company Overview Biotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. The company was incorporated in 1999 and is based in Sydney, Australia. Read More Receive BIT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotron and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BIT Stock News HeadlinesBiocurious: Five years post-pandemic, the Covid ‘hero’ stocks forge a new pathAugust 26, 2025 | msn.comBiotron Advances Antiviral Programs with Successful Funding and Study CompletionJuly 28, 2025 | tipranks.comNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $25 trillion AI revolution — one that Nvidia’s CEO himself has called a “multi-trillion-dollar future industry” — and he’s uncovered a little-known stock 168 times smaller than Nvidia that could be positioned to ride this breakthrough.September 16 at 2:00 AM | Brownstone Research (Ad)Biotron Limited Appoints Michael Medway as Non-Executive DirectorJuly 15, 2025 | tipranks.comBiotron Ltd Stock Price History - Investing.comJune 26, 2025 | investing.comBiotron Advances Hepatitis B Drug Development with Successful Safety StudyJune 23, 2025 | tipranks.comBiotron Limited Announces Investor Webinar to Discuss Recent DevelopmentsMay 22, 2025 | tipranks.comBiotron Limited Advances Antiviral Commercialization with New Funding and Strategic PartnershipsApril 23, 2025 | tipranks.comSee More Headlines BIT Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Biotron own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biotron investors own include TPG Co. Limited (TPM.AX) (TPM), Gemfields Group (GEM), Northern Star Resources (NST), Nokia (NOK), Mesoblast (MESO), Marathon Digital (MARA) and FYI Resources (FYI). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:BIT CIKN/A Webwww.biotron.com.au Phone61 2 9805 0488FaxN/AEmployees3Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-A$3.44 million Net Margins-208.89% Pretax MarginN/A Return on Equity-423.05% Return on Assets-94.68% Debt Debt-to-Equity Ratio-2.92 Current Ratio0.58 Quick Ratio2.32 Sales & Book Value Annual SalesA$1.65 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow6.71 Book ValueA$0.00 per share Price / BookN/AMiscellaneous Outstanding Shares902,310,000Free FloatN/AMarket CapA$9.93 million OptionableNot Optionable Beta-0.61 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (ASX:BIT) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotron Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIT Stock Alerts